$CTIC Company News Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Oct 20, 2014 at 10:02 AM

$CTIC Company News

Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com

InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 8:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 8:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 8:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 1:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 8:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 10:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 10:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 10:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 5:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma (CTIC) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 4, 2014 - Seeking Alpha
Insider Trading Alert - AAWW, CTIC And HBI Traded By Insiders 10:12 a.m. July 10, 2014 - TheStreet.com
$4 Or Less: 2 Small Biotechs Moving On News 11:56 a.m. July 2, 2014 - Seeking Alpha
CTI completes clinical trial enrollment that sets up a milestone payment 7:23 a.m. July 1, 2014 - Seeking Alpha
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:30 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - FII, RP And CTIC Traded By Insiders 10:23 a.m. June 30, 2014 - TheStreet.com
Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders 10:16 a.m. June 9, 2014 - TheStreet.com
Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com

CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 1:30 a.m. Today - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 9:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 1:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 8:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 1:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 10:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 1:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 1:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 6:00 a.m. July 4, 2014 - PR Newswire - PRF
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis 1:30 a.m. July 1, 2014 - PR Newswire - PRF
Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics 7:00 a.m. June 27, 2014 - PR Newswire - PRF
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom 6:00 a.m. June 13, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS 1:30 a.m. June 12, 2014 - PR Newswire - PRF
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Scientel Solutions Connects North Central Athletes on Road

Boosting Connectivity for Student-Athletes Here's a nugget that slips under the radar unless you're looking with both eyes open: Scientel Solutions, from Aurora, Illinois, is shaking up the connectivity game for North Central College's athletic department. These folks have realized something many don't quite grasp—keeping student-athletes connected is no luxury; it's...

Huawei Unleashes Bold New Flagship Devices in Munich

Huawei's Bold Move in Munich When I hear about yet another product launch, I often roll my eyes but this one, folks, deserves a second glance. Huawei dropped a news bomb in Munich with their 'Chase the Wild' event, unveiling a huge lineup of flagship gadgets. This isn't your run-of-the-mill release; the mix of smart wearables, tablets, smartphones, and audio gear marks...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Supercharged Entertainment's Big Bet in Ohio's Polaris

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

DeFi Technologies Gains More Time for Nasdaq Compliance

DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...

Narwal Unveils 2026 AI Cleaning Lineup at IFA Berlin

A Fresh Sweep with AI: Narwal's 2026 Lineup Hot off the press from Berlin's IFA 2026, Narwal is making some serious waves with its latest household cleaning gadgets. This isn't just another batch of robot helpers; Narwal's aiming to redefine what AI-driven cleaning can do for your home. FlowWash: Not Just Another Cleaning Gimmick Narwal's been at this game for over a...

Capricor Faces Lawsuit: Investors Should Take Note

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Ohio's Visionary Leadership Honored with Prestigious Award

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...